Cargando…
COVID severity test (CoST sensor)—An electrochemical immunosensing approach to stratify disease severity
With the evolution of the COVID‐19 pandemic, there is now a need for point‐of‐care devices for the quantification of disease biomarkers toward disease severity assessment. Disease progression has been determined as a multifactor phenomenon and can be treated based on the host immune response within...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486328/ https://www.ncbi.nlm.nih.gov/pubmed/37693054 http://dx.doi.org/10.1002/btm2.10566 |